Cargando…

Through a glass darkly

Detalles Bibliográficos
Autor principal:	Hall, James E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	WILEY-VCH Verlag 2012
Materias:	Closeup
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376833/ https://www.ncbi.nlm.nih.gov/pubmed/22180285 http://dx.doi.org/10.1002/emmm.201100188

Ejemplares similares

A new inducible model for t(8;21) AML
por: Mulloy, James C
Publicado: (2013)

The cancer stem cell model: B cell acute lymphoblastic leukaemia breaks the mould
por: McClellan, James Scott, et al.
Publicado: (2013)

GLI1 finds a new role in cancer stem cell biology
por: Fernandez-Zapico, Martin E
Publicado: (2013)

AMPed up to treat prostate cancer: novel AMPK activators emerge for cancer therapy
por: Schiewer, Matthew J, et al.
Publicado: (2014)

The first MMP in sepsis
por: Vandenbroucke, Roosmarijn E, et al.
Publicado: (2011)

An acute phase protein ready to go therapeutic for sepsis
por: Vandevyver, Sofie, et al.
Publicado: (2014)

A surrogate marker for Aβ42 production in the CNS
por: Holtzman, David M
Publicado: (2009)

In a flurry of PINK, mitochondrial bioenergetics takes a leading role in Parkinson's disease
por: Murphy, Anne N
Publicado: (2009)

Decoding the evolution of a breast cancer genome
por: Bedard, Philippe L, et al.
Publicado: (2010)

Back to the future: a new ‘old’ lead for tuberculosis
por: Wright, Gerard D
Publicado: (2012)

Suppressing nonsense—a surprising function for 5-azacytidine
por: Shao, Ada, et al.
Publicado: (2014)

Telomerase gene therapy: a novel approach to combat aging
por: Boccardi, Virginia, et al.
Publicado: (2012)

Prion protein in Alzheimer's pathogenesis: a hot and controversial issue
por: Benilova, Iryna, et al.
Publicado: (2010)

Interferon-lambda as a new approach for treatment of allergic asthma?
por: Edwards, Michael R, et al.
Publicado: (2011)

A new way APP mismetabolism can lead to Alzheimer's disease
por: Hardy, John, et al.
Publicado: (2011)

Salvaging hope: Is increasing NAD(+) a key to treating mitochondrial myopathy?
por: Lightowlers, Robert N, et al.
Publicado: (2014)

VEGF-B: a more balanced approach toward cardiac neovascularization?
por: Kupatt, Christian, et al.
Publicado: (2014)

High mobility group box-1 recognition: The beginning of a RAGEless era?
por: Branco-Madeira, Filipe, et al.
Publicado: (2010)

Déjà vu with a twist: transglutaminases in bioenergetics and transcriptional dysfunction in Huntington's disease
por: Kazemi-Esfarjani, Parsa, et al.
Publicado: (2010)

Farber disease: understanding a fatal childhood disorder and dissecting ceramide biology
por: Sands, Mark S
Publicado: (2013)

Asthma exacerbations: a molecular dichotomy between antiviral and pro-inflammatory responses revealed
por: Andreakos, Evangelos
Publicado: (2012)

VEGF sticky-trap: the first report of a non-systemically acting angiogenesis inhibitor
por: Favara, David M, et al.
Publicado: (2014)

A magic bullet to specifically eliminate mutated mitochondrial genomes from patients' cells
por: Moraes, Carlos T
Publicado: (2014)

PI3K signaling in the locus coeruleus: a new molecular pathway for ADHD research
por: Darcq, Emmanuel, et al.
Publicado: (2015)

Mixing and matching mitochondrial aminoacyl synthetases and their tRNAs: a new way to treat respiratory chain disorders?
por: Tyynismaa, Henna, et al.
Publicado: (2014)

A new twist to the emerging functions of ceramides in cancer: novel role for platelet acid sphingomyelinase in cancer metastasis
por: Hannun, Yusuf A, et al.
Publicado: (2015)

eEF2K—a new target in breast cancers with combined inactivation of p53 and PTEN
por: Russnes, Hege G, et al.
Publicado: (2014)

TNFα cleavage beyond TACE/ADAM17: matrix metalloproteinase 13 is a potential therapeutic target in sepsis and colitis
por: Becker-Pauly, Christoph, et al.
Publicado: (2013)

Targeting protein–protein interactions to rescue Δf508-cftr: a novel corrector approach to treat cystic fibrosis
por: Devesa, Isabel, et al.
Publicado: (2013)

Inhibition of terminal complement activation in severe Shiga toxin-associated HUS – perfect example for a fast track from bench to bedside
por: Orth-Höller, Dorothea, et al.
Publicado: (2011)

Inositol-requiring 1/X-box-binding protein 1 is a regulatory hub that links endoplasmic reticulum homeostasis with innate immunity and metabolism
por: Kaufman, Randal J, et al.
Publicado: (2010)

p63 and FGFR: when development meets proliferation
por: Dotto, G Paolo
Publicado: (2012)

Exploiting pleiotropic activities of semaphorins as multi-target therapies for cancer
por: Moserle, Lidia, et al.
Publicado: (2012)

Selecting for predisposition to cancer cachexia
por: Gioulbasanis, Ioannis, et al.
Publicado: (2012)

Molecular investigation of Ewing sarcoma: about detecting translocations
por: Blau, Olga
Publicado: (2012)

‘Don't be so over-protective!’
por: Tschachler, Erwin, et al.
Publicado: (2012)

The double-edged sword of fibronectin in atherosclerosis
por: Moore, Kathryn J, et al.
Publicado: (2012)

Dendrimers branch out to support mucosal integrity
por: Kelleher, Dermot
Publicado: (2012)

Novel non-coding RNA-based therapeutic approaches to prevent statin-induced liver damage
por: Bang, Claudia, et al.
Publicado: (2012)

IGF2: The Achilles' heel of p53-deficiency?
por: Clermont, Frederic, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bh8p6754k571f6869f78scchbc